NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | – | 38 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 38 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 38 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 38 | -51.3% | 0.00% | – |
| Q4 2019 | $0 | – | 78 | -35.5% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 121 | -99.7% | 0.00% | – |
| Q2 2019 | $45,000 | +28.6% | 35,119 | +160.4% | 0.00% | – |
| Q1 2019 | $35,000 | – | 13,487 | +16550.6% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 81 | -99.3% | 0.00% | – |
| Q3 2018 | $57,000 | +338.5% | 11,715 | +455.2% | 0.00% | – |
| Q2 2018 | $13,000 | -87.0% | 2,110 | -82.4% | 0.00% | – |
| Q1 2018 | $100,000 | +69.5% | 12,003 | +109.6% | 0.00% | – |
| Q4 2017 | $59,000 | -48.7% | 5,726 | -54.5% | 0.00% | – |
| Q3 2017 | $115,000 | +161.4% | 12,581 | +110.0% | 0.00% | – |
| Q2 2017 | $44,000 | -60.0% | 5,991 | -60.7% | 0.00% | – |
| Q1 2017 | $110,000 | +400.0% | 15,228 | +284.4% | 0.00% | – |
| Q4 2016 | $22,000 | +2100.0% | 3,962 | +4507.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 86 | -53.8% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 186 | +116.3% | 0.00% | – |
| Q1 2016 | $1,000 | -66.7% | 86 | -67.5% | 0.00% | – |
| Q4 2015 | $3,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|